Palisade Bio, Inc. SEC filings PALI
Palisade Bio, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Nov 16, 2011. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 30, 2026 | — |
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 3 | Initial insider ownership | Oct 21, 2026 | Oct 19, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 6, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 6, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 6, 2026 |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 10, 2026 |
| 3 | Initial insider ownership | Jun 18, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 3 | Initial insider ownership | Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| S-8 | Employee stock plan registration | Jun 10, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 27, 2026 | — |
| EFFECT | Filing | May 21, 2026 | — |
| CORRESP | Letter to the SEC | May 19, 2026 | — |
| UPLOAD | Letter from the SEC | May 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| S-3 | Shelf registration | May 12, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| 8-K |
Current report
Other events
|
Apr 2, 2026 | Mar 27, 2026 |
| 10-K | Annual report | Mar 20, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 13, 2026 | Feb 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 10, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2026 | — |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 8, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Dec 4, 2025 | Dec 3, 2025 |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 4/A | Filing | Nov 6, 2025 | Oct 6, 2025 |
| 4/A | Filing | Nov 6, 2025 | Oct 6, 2025 |
| 4/A | Filing | Nov 6, 2025 | Oct 6, 2025 |
| DEFA14A | Additional proxy material | Nov 3, 2025 | — |
| DEF 14A | Proxy statement | Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 20, 2025 | Oct 17, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 17, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Other events
|
Oct 16, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Other events
|
Oct 9, 2025 | Oct 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 9, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 9, 2025 | — |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Oct 8, 2025 | Oct 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 7, 2025 | — |
| DEFA14A | Additional proxy material | Oct 7, 2025 | — |
| 424B4 | Prospectus | Oct 2, 2025 | — |
| S-1MEF | Filing | Oct 1, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| S-1 | Registration statement | Sep 29, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Other events
|
Sep 18, 2025 | Sep 18, 2025 |
| DEF 14A | Proxy statement | Sep 15, 2025 | Sep 15, 2025 |
| ARS | Annual report to shareholders | Sep 15, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Sep 15, 2025 | — |
| PRE 14A | Preliminary proxy statement | Sep 5, 2025 | Sep 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 4, 2025 |
| EFFECT | Filing | Aug 28, 2025 | — |
| CORRESP | Letter to the SEC | Aug 26, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 21, 2025 | — |
| DEF 14A | Proxy statement | Aug 18, 2025 | Aug 18, 2025 |
| S-3 | Shelf registration | Aug 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 25, 2025 | Jul 23, 2025 |
| 4 | Insider transaction | Jul 22, 2025 | Jul 18, 2025 |
| 3 | Initial insider ownership | Jul 17, 2025 | Jul 7, 2025 |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 9, 2025 | Jul 2, 2025 |
| DRS | Filing | Jul 3, 2025 | — |
| RW | Filing | Jun 12, 2025 | — |
| S-1 | Registration statement | May 27, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| DRS | Filing | May 5, 2025 | — |
| 8-K |
Current report
Listing notice
|
May 2, 2025 | Apr 29, 2025 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 424B3 | Prospectus | Dec 17, 2024 | — |
| 424B3 | Prospectus | Dec 17, 2024 | — |
| 424B3 | Prospectus | Dec 17, 2024 | — |
| EFFECT | Filing | Dec 16, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| POS AM | Filing | Dec 13, 2024 | — |
| EFFECT | Filing | Dec 12, 2024 | — |
| CORRESP | Letter to the SEC | Dec 12, 2024 | — |
| CORRESP | Letter to the SEC | Dec 12, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| CORRESP | Letter to the SEC | Dec 10, 2024 | — |
| CORRESP | Letter to the SEC | Dec 10, 2024 | — |
| S-1/A | Amended registration statement | Dec 9, 2024 | — |
| S-1/A | Amended registration statement | Dec 5, 2024 | — |
| FWP | Free writing prospectus | Nov 22, 2024 | — |
| 4 | Insider transaction | Nov 22, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 21, 2024 |
| S-1/A | Amended registration statement | Nov 21, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| S-1 | Registration statement | Oct 30, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Sep 27, 2024 | Sep 27, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 8, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 12, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| ARS | Annual report to shareholders | May 22, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | May 22, 2024 | — |
| DEF 14A | Proxy statement | May 22, 2024 | May 22, 2024 |
| EFFECT | Filing | May 17, 2024 | — |
| 424B3 | Prospectus | May 17, 2024 | — |
| 3 | Initial insider ownership | May 16, 2024 | May 7, 2024 |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
May 10, 2024 | May 10, 2024 |
| D | Filing | May 10, 2024 | — |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| S-3 | Shelf registration | May 8, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Other events
|
Apr 10, 2024 | Apr 10, 2024 |
| EFFECT | Filing | Apr 5, 2024 | — |
| 424B3 | Prospectus | Apr 5, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Apr 5, 2024 | Apr 5, 2024 |
| CORRESP | Letter to the SEC | Apr 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| 8-K |
Current report
Results of operations, Listing notice, Shareholder vote results
|
Mar 27, 2024 | Mar 27, 2024 |
| 10-K | Annual report | Mar 26, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 12, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 6, 2024 | Mar 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| 4 | Insider transaction | Feb 13, 2024 | Feb 9, 2024 |
| 4 | Insider transaction | Feb 13, 2024 | Feb 8, 2024 |
| 4 | Insider transaction | Feb 13, 2024 | Feb 8, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PALI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1357459
- Former names
- PALISADE BIO, INC. (until Oct 30, 2026); Seneca Biopharma, Inc. (until Apr 26, 2021); Neuralstem, Inc. (until Jan 23, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.